JODI PEGG: Open Payments
NPI 1518486745 · BOARDMAN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,729 in 85 payments from 17 companies in 2025. Trend: 2023 $1,693 · 2024 $2,707 · 2025 $2,729
Food & beverage: $2,629Education: $100
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 12 | $556 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $486 |
| Otsuka America Pharmaceutical, Inc. | 9 | $331 |
| Axsome Therapeutics, Inc. | 8 | $295 |
| Teva Pharmaceuticals USA, Inc. | 4 | $253 |
| ABBVIE INC. | 6 | $182 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $138 |
| Alkermes, Inc. | 4 | $116 |
| E.R. Squibb & Sons, L.L.C. | 3 | $74 |
| Neurocrine BioSciences, Inc. | 4 | $70 |
Products named: FANAPT, CAPLYTA, REXULTI, Auvelity, VRAYLAR, AUSTEDO XR, TRINTELLIX, COBENFY.
Industry payments across OH — which companies pay providers there.
